Interestingly, KDM1A expression is required for the maintenance of MLL-FP leukemias and treatment of MLL-FPs with KDM1A inhibitors had a profound effect on leukemic growth in vitro as well as in vivo [275]. Here, KDM1A is linked to leukemia.